Report #2874686

Received Nov 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: —
Onset: Nov 18, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Herpes zoster

Symptom narrative

Suspected case of Herpes Zoster after single dose of Shingrix (series not completed); HZ is not confirmed by PCR, suspected by dermatologist; This non-serious case was reported by a consumer via sales rep and described the occurrence of herpes zoster in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix (unknown arm). On 18-NOV-2025, an unknown time after receiving Shingrix, the patient experienced herpes zoster (Verbatim: Suspected case of Herpes Zoster after single dose of Shingrix (series not completed); HZ is not confirmed by PCR, suspected by dermatologist). The outcome of the herpes zoster was resolving. The reporter considered the herpes zoster to be unrelated to Shingrix. The company considered the herpes zoster to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 20-NOV-2025 The batch number was not provided, and we are unable to contact the reporter.